Lifevantage Corp's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the first quarter 2026 to a ratio of 72.32, above the company average. This is a clear sign of healthy business climate in the Major Pharmaceutical Preparations industry and improving liquidity at their respective customers, during the first quarter 2026. Average collection period, for Lifevantage's accounts receivable remained unchanged at 5 days, in the Sep 30 2026 quarter.

If we take a look into Healthcare sector 5 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Sep 30 2026 from 49 to 75.

What is Receivable Turnover Ratio?
What is Lifevantage Corp Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

LFVN Receivables Turnover Ratio	(Sep 30 2026) I. Quarter	(Jun 30 2026) IV. Quarter	(Mar 31 2026) III. Quarter	(Dec 31 2025) II. Quarter	(Sep 30 2025) I. Quarter
Y / Y Receivable Change	-25.53 %	-9.23 %	-25.31 %	8.1 %	-18.3 %
Y / Y Revenue Change	-20.72 %	-23.02 %	-25.35 %	-28.65 %	0.2 %
Receivable Turnover Ratio (TTM)	72.32	71.73	74.5	74.33	82.48
LFVN's Total Ranking	# 75	# 49	# 56	# 51	#
Accounts Receivable average collection period days	5	5	5	5	4
Seq. Receivable Change	-39.6 %	23.55 %	7.27 %	-6.97 %	-26.38 %
Seq. Revenue Change	-12.41 %	-2.68 %	-9.68 %	2.98 %	-14.96 %

Receivable Turnover Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 3
Healthcare Sector	# 6
Overall Market	# 75

Receivable Turnover Ratio Statistics
High	Average	Low
4.84	3.72	2.75
(Mar 31 2016)		(Dec 31 2021)

News about Lifevantage Corp Receivables Turnover Ratios

An Illuminating Triumph LifeVantages Revolutionary GLP-1 System Unveiled

In this illustrious epoch, wherein the delicate dance of science and nature embarks upon yet another prodigious foray, there emerges from the hallowed halls of LifeVantage Corporation a herald of hope a resplendent beacon illuminating the oft-arduous path of weight management and optimal health. This esteemed establishment of biochemical innovation has recently completed a most successful human clinical trial, showcasing the potency of a novel GLP-1 System, poised to activate weight loss through the subliminal engagement of the corporeal faculties at the cellular level.The praiseworthy results of this pioneering study bespeak an advent of solutions that are as intricate as they are efficacious, promising to streamline one s empirical journey toward health and vitality. Through meticulous scientific inquiry and research, LifeVantage s GLP-1 System emerges, not merely as a remedy to the burgeoning concerns of excess weight that so burden the populace, but rather as a catalyst for a renaissance in healthful living one wherein the very essence of well-being is rejuvenated through the harmonious interplay of molecular symphony and nutritional wisdom.

LFVN Company Profile • Back to LFVN Efficiency Comparisons • Compare LFVN Receivables Turnover Ratio to its Competitors

Financial Statements
Lifevantage's Accounts Receivable	$ 2 Millions	Visit LFVN's Balance sheet
Lifevantage's Sales TTM	$ 171 Millions	Visit LFVN's Income Statement
Sources of LFVN's Revenues		Visit LFVN's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
LFVN's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
LFVN's Growth Rates	LFVN's Roa	LFVN's Inventory Turnover Ratio	LFVN's Dividend Comparisons
LFVN's Profitability Ratios	LFVN's Roi	LFVN's Asset Turnover Ratio	LFVN's Dividend Growth
LFVN's Valuation Ratios	LFVN's Roe	LFVN's Financial Strength Ratios	LFVN's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Sep 30 2026, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Sep 30 2026	Receivable at quarter ending Sep 30 2026
Metagenomi Therapeutics Inc	92.93	$ 7.086 Millions	$ 0.076 Millions
Lifevantage Corp	72.32	$ 171.248 Millions	$ 2.368 Millions
Nurix Therapeutics Inc	70.19	$ 701.936 Millions	$ 10.000 Millions
Humacyte Inc	64.89	$ 32.703 Millions	$ 0.504 Millions
Kiniksa Pharmaceuticals International Plc	40.65	$ 945.963 Millions	$ 23.272 Millions
Innovage Holding Corp	34.59	$ 1,018.359 Millions	$ 29.443 Millions
Fortrea Holdings Inc	29.58	$ 2,666.700 Millions	$ 90.150 Millions
Sonida Senior Living Inc	27.65	$ 638.130 Millions	$ 23.076 Millions
Wave Life Sciences Ltd	24.65	$ 87.296 Millions	$ 3.541 Millions
Lenz Therapeutics Inc	24.39	$ 12.359 Millions	$ 0.507 Millions
Arvinas Inc	20.06	$ 275.300 Millions	$ 13.725 Millions

Date modified: 2026-11-11T13:50:15+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.